A Nationwide Analysis of Changes in Severity and Outcomes of Inflammatory Bowel Disease Hospitalizations
- 1 February 2011
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 15 (2) , 267-276
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and AdultsGastroenterology, 2008
- Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM StudyGastroenterology, 2008
- Colectomy rate in acute severe ulcerative colitis in the infliximab eraDigestive and Liver Disease, 2008
- Trends in Hospitalization Rates for Inflammatory Bowel Disease in the United StatesClinical Gastroenterology and Hepatology, 2007
- Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM TrialGastroenterology, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgeryGut, 2005
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997